MedTrace Logo

Opium Tincture Against Chronic Diarrhea - Patients

NCT05690321 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-04-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the mechanistic anti-propulsive effects of opium tincture on the gastrointestinal tract of a cohort of patients with chronic diarrhea

Conditions

  • Chronic Diarrhea

Interventions

DRUG

Opium tincture

Self-administration of opium tincture (10 mg/ml) as 3x5 drops on day 1-3, 3x10 drops on days 4-6, and 1x10 drops on day 7 in each study period

DRUG

Placebo

Self-administration of placebo (10 mg/ml) as 3x5 drops on day 1-3, 3x10 drops on days 4-6, and 1x10 drops on day 7 in each study period

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Asbjørn Mohr Drewes

    lead OTHER

Principal Investigators

  • Asbjørn Mohr Drewes · Aalborg University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-17
Primary Completion
2023-12-21
Completion
2023-12-21

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05690321 on ClinicalTrials.gov